IPP Bureau
Orchid Pharma reports net loss of Rs 30.90 cr in Q1FY22
By IPP Bureau - August 16, 2021
EPS for the period at Rs. (7.57)
Glenmark Pharmaceuticals net profit at Rs 306.52 crores in Q1FY22
By IPP Bureau - August 16, 2021
The company reports revenue growth of 26% and PAT growth of 21% YoY
Apollo Hospitals PAT at Rs 489.28 cr. in Q1FY22
By IPP Bureau - August 16, 2021
The hospital chain aggressively embarks on digitisation and is e-health ready
.jpg "Antiviral face mask capable of inactivating COVID19")
Antiviral face mask capable of inactivating COVID19
By IPP Bureau - August 16, 2021
The antiviral technology involves the presence of active positive charges on the fabric, as binding sites for viruses and on contact with the fabric, virus cells that are negatively charged are neutralised, leading to the rapid destruction of their glycoprotein layers and the release of non-infectious ribonucleic acid (RNA)
Zydus Cadila receives final approval for Mesalamine extended-release capsules
By IPP Bureau - August 16, 2021
The group has a total of 320 ANDA approvals
Nanavati Max is the first in Mumbai to receive NABH-MIS accreditation
By IPP Bureau - August 16, 2021
National Accreditation Board for Hospitals & Healthcare Providers (NABH) is a constituent board of the Quality Council of India, set up to establish and operate accreditation programmes for healthcare organisations
India restricts export of Rapid Antigen Test Kits used to detect Covid 19
By IPP Bureau - August 16, 2021
The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT
Apollo Hospitals inks MoU with Group of Hospitals for liver transplant
By IPP Bureau - August 14, 2021
The MoU was signed on World Organ Donation Day which falls on August 13
Bharat Biotech’s first nasal vaccine gets approval for Phase 2 trials
By IPP Bureau - August 14, 2021
This is the first of its kind vaccine for Covid 19 to get the go-ahead
Indian Immunologicals receive manufacturing license for Covaxin drug substance
By IPP Bureau - August 14, 2021
It falls under the Department of Biotechnology - Mission Covid Suraksha Project for augmenting manufacturing capacity for Covaxin
Novatek Pharma initiates Phase II study of oral COVID-19 drug
By IPP Bureau - August 14, 2021
This therapy may provide the first potential oral treatment for COVID-19, recognizing the global emergency of new SARS-CoV-2 variants
India observes its first `Prediabetes Day' on August 14
By IPP Bureau - August 14, 2021
Fitterfly has launched an online Prediabetes risk test which is an evidence-based, clinically validated tool for assessing an individual's risk of Prediabetes
Study shows Moderna vaccine maintains antibodies against Variants of Concern and Interest
By IPP Bureau - August 13, 2021
Studies include Alpha, Beta, Gamma, Delta, Epsilon and Iota and it maintains antibodies for six months after the second dose
Aurobindo Pharma buys Cronus Pharma Specialities for Rs 420 crores
By IPP Bureau - August 13, 2021
The acquisition will provide it with a foothold in the US $ 48 billion global animal health market
